NewsWhore
09-20-2010, 02:30 PM
-(Dow Jones)- Adding an experimental diabetes drug co-developed by AstraZeneca PLC (AZN) and Bristol-Myers Squibb Co. (BMY) to the standard treatment glimepiride reduced a measure of blood sugar ver...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/38812380/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/38812380/)